TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
19 hedge funds and large institutions have $4.27M invested in Talis Biomedical Corporation Common Stock in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$86.1K | |
| 2 | +$65.9K | |
| 3 | +$30.3K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$11K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.4K |
Top Sellers
| 1 | -$43.9K | |
| 2 | -$26K | |
| 3 | -$23.5K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$22.8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$18.7K |